Biodegradation and biocompatibility of PLA and PLGA microspheres

Advanced Drug Delivery Reviews

Volumn 64, Issue SUPPL., 2012, Pages 72-82

  Anderson, James M ^a   Shive, Matthew S ^a  

^a Case Western Reserve University   (United States)

Author keywords

Foreign body giant cells; Foreign body response; Hydrolytic degradation; In vivo tissue response; Inflammatory response; Macrophages; Therapeutic agent release

Indexed keywords

FOREIGN BODY GIANT CELLS; FOREIGN BODY RESPONSE; HYDROLYTIC DEGRADATION; IN-VIVO; INFLAMMATORY RESPONSE; THERAPEUTIC AGENTS;

BIOCOMPATIBILITY; COPOLYMERS; MACROPHAGES; MICROBIOLOGY; MICROSPHERES; TISSUE;

BIODEGRADATION;

BETA GLUCURONIDASE; BONE MORPHOGENETIC PROTEIN; BUPIVACAINE; CARBON 14; CISPLATIN; COPOLYMER; DEXAMETHASONE; ERGOT ALKALOID; EXCIPIENT; GENTAMICIN; GLYCOLIC ACID; HYDROCORTISONE; LACTATE DEHYDROGENASE; LACTIC ACID; LEUPRORELIN; LYPRESSIN; MICROSPHERE; NALTREXONE; NANOPARTICLE; NANOSPHERE; NORETHISTERONE; OPIATE AGONIST; OPIATE ANTAGONIST; POLYGLACTIN; POLYLACTIC ACID; POLYMER; PREDNISOLONE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; SILASTIC; UNINDEXED DRUG;

BIOCOMPATIBILITY; BIODEGRADATION; CENTRAL NERVOUS SYSTEM; CONTROLLED DRUG RELEASE; EYE; FOREIGN BODY REACTION; IN VIVO STUDY; LYMPHOID TISSUE; MATERIALS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE INTERACTION; VACCINE PRODUCTION;

EID: 84870238185     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2012.09.004     Document Type: Review

References (74)

1. Anderson J.M. In vivo biocompatibility of implantable delivery systems and biomaterials. Eur. J. Pharm. Biopharm. 1994, 40:1-8.
2. Anderson J.M. Mechanisms of inflammation and infection with implanted devices. Cardiovasc. Pathol. 1993, 2(3, Suppl.):33S-41S.
3. Anderson J.M. Perspectives on the in vivo responses of biodegradable polymers. Biomedical Applications of Synthetic Biodegradable Polymers 1995, 223-233. CRC Press, Boca Raton, FL. J.O. Hollinger (Ed.).
4. Anderson J.M. Inflammation and the foreign body response. Probl. Gen. Surg. 1994, 11:147-160.
5. Okada H., Toguchi H. Biodegradable microspheres in drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 1995, 12:1-99.
6. Li S., Vert M. Biodegradation of aliphatic polyesters. Degradable Polymers 1995, 43-87. Chapman and Hall, London, Chapter 4. G. Scott, D. Gilead (Eds.).
7. Schakenraad J.M., Hardon M.J., Feijen J., Molenaar I., Nieuwenhuis P. Enzymatic activity toward poly(L-lactic acid) implants. J. Biomed. Mater. Res. 1990, 24:529-545.
8. Spenlehauer G., Vert M., Benoit J.P., Boddaert A. In vitro and in vivo degradation of poly(DL- lactide/glycolide) type microspheres made by solvent evaporation method. Biomaterials 1989, 10:557-563.
9. Vert M., Mauduit J., Li S. Biodegradation of PLA/GA polymers: increasing complexity. Biomaterials 1994, 15:1209-1213.
10. Grizzi I., Garreau H., Li S., Vert M. Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence. Biomaterials 1995, 16:305-311.
11. Vert M., Li S.M., Garreau H. Attempts to map the structure and degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids. J. Biomater. Sci. Polym. Ed. 1994, 6:639-649.
12. Vert M., Li S., Garreau H. Recent advances in the field of lactic acid/glycolic acid polymer-based therapeutic systems. Macromol. Symp. 1995, 98:633-642.
13. Visscher G.E., Robison R.L., Maulding H.V., Fong J.W., Pearson J.E., Argentieri G.J. Biodegradation of and tissue reaction to 50:50 poly(DL-lactide-co-glycolide) microcapsules. J. Biomed. Mater. Res. 1985, 19:349-365.
14. Visscher G.E., Robison R.L., Maulding H.V., Fong J.W., Pearson J.E., Argentieri G.J. Note: Biodegradation of and tissue reaction to poly(DL-lactide) microcapsules. J. Biomed. Mater. Res. 1986, 20:667-676.
15. Visscher G.E., Robison R.L., Argentieri G.J. Tissue response to biodegradable injectable microcapsules. J. Biomater. Appl. 1987, 2:118-130.
16. Visscher G.E., Pearson J.E., Fong J.W., Argentieri G.J., Robison R.L., Maulding H.V. Effect of particle size on the in vitro and in vivo degradation rates of poly(DL-lactide-co-glycolide) microcapsules. J. Biomed. Mater. Res. 1988, 22:733-746.
17. Tabata Y., Ikada Y. Macrophage phagocytosis of biodegradable microspheres composed of l-lactic acid/glycolic acid homo- and copolymers. J. Biomed. Mater. Res. 1988, 22:837-858.
18. Tabata Y., Ikada Y. Protein precoating of polylactide microspheres containing a lipophilic immunopotentiator for enhancement of macrophage phagocytosis and activation. Pharm. Res. 1989, 6:296-301.
19. Tabata Y., Ikada Y. Phagocytosis of polymer microspheres by macrophages. Adv. Polym. Sci. 1990, 94:107-141.
20. Beck L.R., Cowsar D.R., Lewis D.H. Systemic and local delivery of contraceptive steroids using biodegradable microspheres. Biodegradables and Delivery Systems for Contraception, 1 1980, 63-82. MTP Press Limited. E.S.E. Hafez, W.A.A. Van Os (Eds.).
21. Tice T.R., Lewis D.H., Dunn R.L., Meyers W.E., Casper R.A., Cowsar D.R. Biodegradation of microspheres and biomedical devices prepared with resorbable polyesters. 9th International Symposium on Controlled Release of Bioactive Materials 1982, 21-25. The Controlled Release Society, Inc.
22. Tice T.R., Tabibi S.E. Parenteral drug delivery: Injectables. Treatise on Controlled Drug Delivery 1992, 315-339. Marcel Dekker, Inc., New York. A. Kydonieus (Ed.).
23. Maulding H.V., Tice T.R., Cowsar D.R., Fong J.W., Pearson J.E., Nazareno J.P. Biodegradable microcapsules: acceleration of polymeric excipient hydrolytic rate by incorporation of a basic medicament. J. Control. Release 1986, 3:103-117.
24. Pistner H., Bendix D.R., Muhling J., Reuther J.F. Poly(L-lactide): a long-term degradation study in vivo Part III. Analytical characterization. Biomaterials 1993, 14:291-304.
25. Bostman O., Hirvensalo E., Makinen J., Rokkanen P. Foreign-body reactions to fracture fixation implants of biodegradable synthetic polymers. J. Bone Joint Surg. Br. 1990, 72B:592-596.
26. Bergsma E.J., Rozema F.R., Bos R.R.M., De Bruijn W.C. Foreign body reactions to resorbable poly(L-lactide) bone plates and screws used for fixation of unstable zygomatic fractures. J. Oral Maxillofac. Surg. 1993, 51:666-670.
27. Bostman O. Intense granulomatous in inflammatory lesions associated with absorbable internal fixation devices made of polyglycolide in ankle fractures. Clin. Orthop. Relat. Res. 1992, 778:178-199.
28. F.R. Rozema, Resorbable poly(l-lactide) bone plates and screws: Tests and applications. Academisch Ziekenhuis Groningen, Afdeling Mondziektenen Kaakchirurgie-Ill. Thesis, Groningen University, 1991.
29. Isobe M., Yamazaki Y., Oida S-i., Ishihara K., Nakabayashi N., Amagasa T. Bone morphogenetic protein encapsulated with a biodegradable and biocompatible polymer. J. Biomed. Mater. Res. 1996, 32:433-438.
30. Kamei S., Inoue Y., Okada H., Yamada M., Ogawa Y., Toguchi H. New method for analysis of biodegradable polyesters by high-performance liquid chromatography after alkali hydrolysis. Biomaterials 1992, 13:953-958.
31. Heya T., Okada H., Ogawa Y., Toguchi H. In vitro and in vivo evaluation of thyrotrophin releasing hormone release from copoly(DL-lactic/glycolic acid) microspheres. J. Pharm. Sci. 1994, 83:636-640.
32. McNally A.K., Anderson J.M. Interleukin-4 induces foreign body giant cells from human monocytes/macrophages. Differential lymphokine regulation of macrophage fusion leads to morphological variants of multinucleated giant cells. Am. J. Pathol. 1995, 147:1487-1499.
33. Yamaguchi K., Anderson J.M. In vivo biocompatibility studies of medisorb® 65/35 dl-lactide/glycolide copolymer microspheres. J. Control. Release 1993, 24:81-93.
34. Yamaguchi K., Anderson J.M. Biocompatibility studies of naltrexone sustained release formulations. J. Control. Release 1992, 19:299-314.
35. Anderson J.M., Marchant R., McClurken M. Tissue response to drug delivery systems: the cage implant system. Long-Acting Contraceptive Delivery Systems 1984, 248-255. Harper and Row, Chapter 23. G.I. Zatuchni, A. Goldsmith, J.D. Shelton, J.J. Sciarra (Eds.).
36. Spilizewski K.L., Marchant R.E., Hamlin C.R., Anderson J.M., Tice T.R., Dappert T.O., Meyers W.E. The effect of hydrocortisone acetated loaded poly(dl-lactide) films on the inflammatory response. J. Control. Release 1985, 2:197-203.
37. Ike O., Shimizu Y., Wada R., Hyon S.-H., Ikada Y. Controlled cisplatin delivery system using poly(dl-lactic acid). Biomaterials 1992, 13:230-234.
38. Itoi K., Tabata C.-Y., Ike O., Shimizu Y., Kuwabara M., Kyo M., Hyon S.H., Ikada Y. In vivo suppressive effects of copoly(glycolic/L-lactic acid) microspheres containing CDDP on murine tumor cells. J. Control. Release 1996, 42:175-184.
39. Curley J., Castillo J., Hotz J., Uezono M., Hernandez S., Lim J.-O., Tigner J., Chasin M., Langer R., Berde C. Prolonged regional nerve blockade. Injectable biodegradable bupivacaine/polyester microspheres. Anesthesiology 1996, 84:1401-1409.
40. Smith A., Hunneyball I.M. Evaluation of poly(lactic acid) as a biodegradable drug delivery system for parenteral administration. Int. J. Pharm. 1986, 30:215-220.
41. Kenley R., Marden L., Turek T., Jin L., Ron E., Hollinger J.O. Osseous regeneration in the rat calvarium using novel delivery systems for recombinant human bone morphogenetic protein-2 (rhBMP-2). J. Biomed. Mater. Res. 1994, 28:1139-1147.
42. Lee S.C., Shea M., Battle M.A., Kozitza K., Ron E., Turek T., Schaub R.G., Hayes W.C. Healing of large segmental defects in rat femurs is aided by RhBMP-2 in PLGA matrix. J. Biomed. Mater. Res. 1994, 28:1149-1156.
43. Saitoh H., Takata T., Nikai H., Shintani H., Hyon S.-H., Ikada Y. Effect of polylactic acid on osteoinduction of demineralized bone: preliminary study of the usefulness of polylactic acid as a carrier of bone morphogenetic protein. J. Oral Rehabil. 1994, 21:431-438.
44. Mayer M., Hollinger J., Ron E., Wozney J. Maxillary alveolar cleft repair in dogs using recombinant human bone morphogenetic protein-2 and a polymer carrier. Plast. Reconstr. Surg. 1996, 98:247-259.
45. Turk A.E., Ishida K., Jensen J.A., Wollman J.S., Miller T.A. Enhanced healing of large cranial defects by an osteoinductive protein in rabbits. Plast. Reconstr. Surg. 1993, 92:593-600.
46. Hollinger J., Mayer M., Buck D., Zegzula H., Ron E., Smith J., Lin L., Wozney J. Poly(α-hydroxy acid) carrier for delivering recombinant human bone morphogenetic protein-2 for bone regeneration. J. Control. Release 1996, 39:287-304.
47. Hollinger J.O., Brekke J., Gruskin E., Lee D. Role of bone substitutes. Clin. Orthop. Relat. Res. 1996, 324:55-65.
48. Hollinger J.O., Leong K. Poly(α-hydroxy acids): carriers for bone morphogenetic proteins. Biomaterials 1996, 17:187-194.
49. Winet H., Hollinger J.O., Stevanovic M. Incorporation of polylactide-polyglycolide in a cortical defect: neoangiogenesis and blood supply in a bone chamber. J. Orthop. Res. 1995, 13:679-689.
50. Ogura Y., Kimura H. Biodegradable polymer microspheres for targeted drug delivery to the retinal pigment epithelium. Surv. Ophthalmol. 1995, 39:S-17-S-24. (Suppl.).
51. Ogawa Y., Okada H., Yamamoto M., Shimamoto T. In vivo release profiles of leuprolide acetate from microcapsules prepared with polylactic acids or copoly(lactic/glycolic) acids and in vivo degradation of these polymers. Chem. Pharm. Bull. 1988, 36:2576-2581.
52. Menei P., Daniel V., Montero-Menei C., Brouillard M., Pouplard-Barthelaix A., Benoit J.P. Biodegradation and brain tissue reaction to poly(dl-lactide-co-glycolide) microspheres. Biomaterials 1993, 14:470-478.
53. McRae A., Dahlström A., Hjorth S., Ling E.A., Mason D., Tice T. Catecholamine-containing biodegradable microsphere implants: an overview of experimental studies in dopamine-lesioned rats. Alzheimer's and Parkinson's Disease 1995, 421-427. Plenum Press, New York. I. Hannin (Ed.).
54. McRae A., Ling E.A., Hjorth S., Dahlström A., Mason D., Tice T. Catecholamine-containing biodegradable microsphere implants as a novel approach in the treatment of CNS neurodegenerative disease. A review of experimental studies in DA-lesioned rats. Mol. Neurobiol. 1994, 9:191-205.
55. McRae A., Hjorth S., Dahlström A., Dillon L., Mason D., Tice T. Dopamine fiber growth induction by implantation of synthetic dopamine-containing microspheres in rats with experimental hemi-Parkinsonism. Mol. Chem. Neuropathol. 1992, 16:123-141.
56. Leroux J.-C., Allémann E., De Jaeghere F., Doelker E., Gurny R. Biodegradable nanoparticles - from sustained release formulations to improved site specific drug delivery. J. Control. Release 1996, 39:339-350.
57. Gref R., Minamitake Y., Peracchia M.T., Trubetskoy V., Torchilin V., Langer R. Biodegradable long-circulating polymeric nanospheres. Science 1994, 263:1600-1602.
58. Allémann E., Gurny R., Doelker E. Drug-loaded nanoparticles - preparation methods and drug targeting issues. Eur. J. Pharm. Biopharm. 1993, 39:173-191.
59. Allémann E., Brasseur N., Benrezzak O., Rousseau J., Kudrevich S.V., Boyle R.W., Leroux J.-C., Gurny R., Van Lier J.E. PEG-coated poly(lactic acid) nanoparticles for the delivery of hexadecafluoro zinc phthalocyanine to EMT-6 mouse mammary tumours. J. Pharm. Pharmacol. 1995, 47:382-387.
60. Allémann E., Rousseau J., Brasseur N., Kudrevich S.V., Lewis K., Van Lier J.E. Photodynamic therapy of tumours with hexadecafluoro zinc phthalocyanine formulated in PEG-coated poly(lactic acid) nanoparticles. Int. J. Cancer 1996, 66:821-824.
61. Leroux J.-C., De Jaeghere F., Anner B., Doelker E., Gurny R. An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(dl-lactic acid) nanoparticles by human monocytes. Life Sci. 1995, 57:695-703.
62. E. Allémann, P. Gravel, J.-C. Leroux, L. Balant, R. Gurny, Kinetics of blood components adsorption on poly(dl-lactic acid) nanoparticles - evidence of complement C3 component involvement. J. Biomed. Mater. Res. (in press).
63. Fernández-Urrusuno R., Fattal E., Rodrigues J.M., Féger J., Bedossa P., Couvreur P. Effect of polymeric nanoparticle administration on the clearance activity of the mononuclear phagocyte system in mice. J. Biomed. Mater. Res. 1996, 31:401-408.
64. Fernández-Urrusuno R., Fattal E., Porquet D., Féger J., Couvreur P. Influence of surface properties on the inflammatory response to polymeric nanoparticles. Pharm. Res. 1995, 12:1385-1387.
65. Ronneberger B., Kissel T., Anderson J.M. Biocompatibility of ABA triblock copolymer microparticles consisting of poly(l-lactic-co-glycolic acid) A-blocks attached to central poly(oxyethylene) B-blocks in rats after intramuscular injection. Eur. J. Pharm. Biopharm. 1997, 43:19-28.
66. Gref R., Domb A., Quellec P., Blunk T., Müller R.H., Verbavatz J.M., Langer R. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv. Drug Deliv. Rev. 1995, 16:215-233.
67. Ronneberger B., Kao W.J., Anderson J.M., Kissel T. In vivo biocompatibility study of ABA triblock copolymers consisting of poly(l-lactic-co-glycolic acid) A blocks attached to central poly(oxyethylene) B blocks. J. Biomed. Mater. Res. 1996, 30:31-40.
68. Ermak T.H., Dougherty E.P., Bhagat H.R., Kabok Z., Pappo J. Uptake and transport of copolymer biodegradable microspheres by rabbit Peyer's patch M cells. Cell Tissue Res. 1995, 279:433-436.
69. Eldridge J.H., Hammond C.J., Meulbroek J.A., Staas J.K., Gilley R.M., Tice T.R. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches. J. Control. Release 1990, 11:205-214.
70. Eldridge J.H., Gilley R.M., Staas J.K., Moldoveanu Z., Meulbroek J.A., Tice T.R. Biodegradable microspheres: vaccine delivery system for oral immunization. Curr. Top. Microbiol. Immunol. 1989, 146:59-66.
71. Eldridge J.H., Staas J.K., Meulbroek J.A., McGhee J.R., Tice T.R., Gilley R.M. Biodegradable microspheres as a vaccine delivery system. Mol. Immunol. 1991, 28:287-294.
72. Eldridge J.H., Staas J.K., Meulbroek J.A., Tice T.R., Gilley R.M. Biodegradable and biocompatible poly(dl-lactide-co-glycolide) microspheres as an adjuvant for Staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies. Infect. Immun. 1991, 59:2978-2986.
73. Eldridge J.H., Staas J.K., Tice T.R., Gilley R.M. Pulsatile delivery of vaccines. Pulsatile Drug Delivery - Current Applications and Future Trends 1993, 163-176. Wissenschaffliche Verlags Gesellschaft, Stuttgart. R. Gurny, H.E. Junginger, N.A. Peppas (Eds.).
74. Thomasin C., Corradin G., Men Y., Merkle H.P., Gander B. Tetanus toxoid and synthetic malaria antigen containing poly(lactide)/poly(lactide-co-glycolide) microspheres: importance of polymer degradation and antigen release for immune response. J. Control. Release 1996, 41:131-145.